Other health services
REVILO AS
Revenue 2024
NOK 3.1m
Operating profit
NOK 118,000
Equity
NOK 3.4m
Incorporated
2011
Share capital
NOK 100,000
Roles
Daglig lederOliver Franz
Regnskapsfører
Styrets lederOliver Franz
VaramedlemTone Askildsen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| OLIVER FRANZ | 100.0% | 100.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| PCI BIOTECH HOLDING ASA | In liquidation | 0.2% | 60000.000000 |
| SPOTLIO AS | Active | 0.1% | 200000.000000 |
| PEXIP HOLDING ASA | Active | 0.1% | 60000.000000 |
| OTOVO ASA | Active | 0.0% | 125000.000000 |
| ZAPTEC ASA | Active | 0.0% | 20000.000000 |
| NYKODE THERAPEUTICS ASA | Active | 0.0% | 60000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.